News

Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…

1 year ago

Inovalon’s Cloud Data Platform Dominates, Ranked #1 by Health Plan and Payer Clients for Fourth Straight Year in 2024 Black Book Survey

LAS VEGAS, NV / ACCESSWIRE / June 27, 2024 / Black Book Research has declared Inovalon the unrivaled leader in…

1 year ago

Nordic Wellness Expands Portfolio With Acquisition of Peak Flow, Rebranded as Nordic Flow

CHARLESTON, SC / ACCESSWIRE / June 27, 2024 / Nordic Wellness, a leading provider of health and wellness solutions, is…

1 year ago

Genflow Biosciences Plc Announces Result of AGM

LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging…

1 year ago

NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson’s Disease Treatments

ZURICH, SWITZERLAND / ACCESSWIRE / June 27, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

1 year ago

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

TORONTO, ON / ACCESSWIRE / June 27, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to…

1 year ago

RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting

GENEVA, SWITZERLAND / ACCESSWIRE / June 27, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), a…

1 year ago

Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform

First-of-its-kind stall-side testing to enable rapid, life-saving decisions for equine veterinarians ANN ARBOR, MI / ACCESSWIRE / June 27, 2024…

1 year ago

Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering

ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company…

1 year ago